ArticleScientific reports2026
Diversity of culturable gut bacteria associated with brown planthopper, Nilaparvata lugens (Stål) and their role in imidacloprid degradation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The brown planthopper, Nilaparvata lugens (Stål), is a major pest of rice across Asia and has developed significant metabolic resistance to multiple insecticides. Microbiome-mediated insecticide resistance is of emerging interest in various insect pests, including N. lugens. In this study, we assessed the diversity of culturable gut bacteria in imidacloprid-susceptible (IMI-S) and imidacloprid-resistant (IMI-R) populations of N. lugens and their potential to degrade imidacloprid. Molecular characterization and phylogenetic analysis identified 13 bacterial isolates, representing ten families from three phyla: Proteobacteria, Actinobacteria and Firmicutes. The IMI-R population has contributed to nine of the 13 isolates. Screening for imidacloprid degradation identified four bacterial strains viz., Paenibacillus amylolyticus, Serratia marcescens, Acinetobacter soli and Brucella sp. associated with the IMI-R population were capable of growing in minimal salt medium supplemented with imidacloprid. Notably, S. marcescens and P. amylolyticus could utilize imidacloprid as a sole source of carbon and nitrogen, respectively. LC-MS/MS analysis revealed that P. amylolyticus and S. marcescens after 14 days of inoculation degraded 73.07 and 66.92% of imidacloprid (100 mg/L), respectively. These findings underscore a strong association between gut-microbial composition and insecticide resistance in N. lugens and highlight the potential of specific bacterial strains for microbiome-based pest and resistance management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.